Search research articles
Contact Us
Filters
Showing results (261-270 of 319) with videos related to
Page
of 32
Sort By:
Nature Medicine
|
June 28, 2011
Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition
Neil Johnson, Yu-Chen Li, Zandra E Walton, et al.
Molecular Cell
|
October 16, 2020
Control of Glucocorticoid Receptor Levels by PTEN Establishes a Failsafe Mechanism for Tumor Suppression
Hon Yan K Yip, Annabel Chee, Ching-Seng Ang, et al.
Cell
|
April 29, 2014
Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function
Antonella Papa, Lixin Wan, Massimo Bonora, et al.
Nature
|
April 8, 2011
Suppression of lung adenocarcinoma progression by Nkx2-1
Monte M Winslow, Talya L Dayton, Roel G W Verhaak, et al.
Science Advances
|
February 1, 2021
Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberin
Pike-See Cheah, Shilpa Prabhakar, David Yellen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 21, 2020
Targeting the cyclin-dependent kinase 5 in metastatic melanoma
Samanta Sharma, Tian Zhang, Wojciech Michowski, et al.
Cell Metabolism
|
February 7, 2017
Parathyroid Hormone Directs Bone Marrow Mesenchymal Cell Fate
Yi Fan, Jun-Ichi Hanai, Phuong T Le, et al.
Cancer Cell
|
October 26, 2002
Slug, a highly conserved zinc finger transcriptional repressor, protects hematopoietic progenitor cells from radiation-induced apoptosis in vivo
Akira Inoue, Markus G Seidel, Wenshu Wu, et al.
Cancer Cell
|
August 14, 2014
Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor
Gang Lu, Qing Zhang, Ying Huang, et al.
Oncotarget
|
December 5, 2015
Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model
Mark Duquette, Peter M Sadow, Amjad Husain, et al.
Page
of 32
Search research articles
Search
Showing results (261-270 of 319) with videos related to
Sort By:
Page
of 32
Nature Medicine
|
June 28, 2011
Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition
Neil Johnson, Yu-Chen Li, Zandra E Walton, et al.
Molecular Cell
|
October 16, 2020
Control of Glucocorticoid Receptor Levels by PTEN Establishes a Failsafe Mechanism for Tumor Suppression
Hon Yan K Yip, Annabel Chee, Ching-Seng Ang, et al.
Cell
|
April 29, 2014
Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function
Antonella Papa, Lixin Wan, Massimo Bonora, et al.
Nature
|
April 8, 2011
Suppression of lung adenocarcinoma progression by Nkx2-1
Monte M Winslow, Talya L Dayton, Roel G W Verhaak, et al.
Science Advances
|
February 1, 2021
Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberin
Pike-See Cheah, Shilpa Prabhakar, David Yellen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 21, 2020
Targeting the cyclin-dependent kinase 5 in metastatic melanoma
Samanta Sharma, Tian Zhang, Wojciech Michowski, et al.
Cell Metabolism
|
February 7, 2017
Parathyroid Hormone Directs Bone Marrow Mesenchymal Cell Fate
Yi Fan, Jun-Ichi Hanai, Phuong T Le, et al.
Cancer Cell
|
October 26, 2002
Slug, a highly conserved zinc finger transcriptional repressor, protects hematopoietic progenitor cells from radiation-induced apoptosis in vivo
Akira Inoue, Markus G Seidel, Wenshu Wu, et al.
Cancer Cell
|
August 14, 2014
Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor
Gang Lu, Qing Zhang, Ying Huang, et al.
Oncotarget
|
December 5, 2015
Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model
Mark Duquette, Peter M Sadow, Amjad Husain, et al.
Page
of 32